Management of community-acquired pneumonia in older adults

AF Simonetti, D Viasus… - … in infectious disease, 2014 - journals.sagepub.com
Community-acquired pneumonia (CAP) is an increasing problem among the elderly.
Multiple factors related to ageing, such as comorbidities, nutritional status and swallowing …

An update on Legionella

J Carratalą, C Garcia-Vidal - Current opinion in infectious diseases, 2010 - journals.lww.com
Legionnaires' disease is a significant health problem in many countries. Clinical
manifestations are unreliable in diagnosing Legionnaires' disease. Therefore, diagnostic …

[HTML][HTML] Legionnaires' disease: update on diagnosis and treatment

D Viasus, V Gaia, C Manzur-Barbur… - Infectious Diseases and …, 2022 - Springer
Legionellosis is the infection caused by bacteria of the genus Legionella, including a non-
pneumonic influenza-like syndrome, and Legionnaires' disease is a more serious illness …

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America …

AC Kalil, ML Metersky, M Klompas… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Health care–associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes

J Carratalą, A Mykietiuk… - Archives of internal …, 2007 - jamanetwork.com
Background Health care–associated pneumonia (HCAP) has been proposed as a new
category of respiratory infection. However, limited data exist to validate this entity. We aimed …

Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes

N Fernįndez-Sabé, J Carratalą, B Rosón, J Dorca… - Medicine, 2003 - journals.lww.com
We performed an observational analysis of pro-spectively collected data on 1,474 adult
patients who were hospitalized for community-acquired pneumonia; 1,169 patients were …

Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases …

AC Kalil, ML Metersky, M Klompas… - Clinical Infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

[HTML][HTML] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

IO Rosas, G Diaz, RL Gottlieb, SM Lobo… - Intensive care …, 2021 - Springer
Purpose Trials of tocilizumab in patients with severe COVID-19 pneumonia have
demonstrated mixed results, and the role of tocilizumab in combination with other treatments …

Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled …

J Carratalą, C Garcia-Vidal, L Ortega… - Archives of internal …, 2012 - jamanetwork.com
Background The length of hospital stay (LOS) for community-acquired pneumonia (CAP)
varies considerably, even though this factor has a major impact on the cost of care. We …

[HTML][HTML] Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial

S Fernįndez-Serrano, J Dorca, C Garcia-Vidal… - Critical Care, 2011 - Springer
Introduction The benefit of corticosteroids as adjunctive treatment in patients with severe
community-acquired pneumonia (CAP) requiring hospital admission remains unclear. This …